Nektar Therapeutics financial data

Symbol
NKTR on Nasdaq
Location
455 Mission Bay Boulevard South, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355 % -34.1%
Quick Ratio 12.9 % -61.9%
Debt-to-equity 690 % +152%
Return On Equity -357 % -105%
Return On Assets -45.2 % +3.01%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.3M shares -89%
Common Stock, Shares, Outstanding 19.7M shares -89.3%
Entity Public Float 226M USD +107%
Common Stock, Value, Issued 2K USD -89.5%
Weighted Average Number of Shares Outstanding, Basic 18.9M shares +35.8%
Weighted Average Number of Shares Outstanding, Diluted 18.9M shares +35.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 62.6M USD -32.8%
Research and Development Expense 116M USD -4.7%
General and Administrative Expense 74.6M USD -3.01%
Costs and Expenses 161M USD -34.7%
Operating Income (Loss) -98.1M USD +35.9%
Nonoperating Income (Expense) -15.7M USD -2.89%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -119M USD +56.9%
Income Tax Expense (Benefit) -428K USD -4656%
Net Income (Loss) Attributable to Parent -121M USD +28.3%
Earnings Per Share, Basic 0 USD/shares +29.7%
Earnings Per Share, Diluted 0 USD/shares +29.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 41M USD +36.3%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Other Assets, Current 11.1M USD +24.8%
Assets, Current 281M USD -1.79%
Property, Plant and Equipment, Net 2.83M USD -21.6%
Operating Lease, Right-of-Use Asset 7.17M USD -18.8%
Goodwill 0 USD -100%
Other Assets, Noncurrent 5.16M USD +14.1%
Assets 301M USD -2.15%
Accounts Payable, Current 15.6M USD +81.5%
Employee-related Liabilities, Current 8.61M USD +22.8%
Accrued Liabilities, Current 28.6M USD -11.7%
Liabilities, Current 66.3M USD -1.84%
Operating Lease, Liability, Noncurrent 69.7M USD -19.6%
Other Liabilities, Noncurrent 5.03M USD -27.3%
Liabilities 216M USD -16.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 56K USD -84.2%
Retained Earnings (Accumulated Deficit) -3.72B USD -3.35%
Stockholders' Equity Attributable to Parent 85.1M USD +74.1%
Liabilities and Equity 301M USD -2.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.1M USD -2.43%
Net Cash Provided by (Used in) Financing Activities 42M USD
Net Cash Provided by (Used in) Investing Activities 43.7M USD +127%
Common Stock, Shares Authorized 390M shares +30%
Common Stock, Shares, Issued 19.7M shares -89.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.36M USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41M USD +36.3%
Deferred Tax Assets, Valuation Allowance 859M USD +0.53%
Deferred Tax Assets, Gross 862M USD +0.45%
Operating Lease, Liability 103M USD -12.9%
Payments to Acquire Property, Plant, and Equipment 157K USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -121M USD +25.1%
Lessee, Operating Lease, Liability, to be Paid 119M USD -15.4%
Operating Lease, Liability, Current 22.2M USD +3.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23M USD +3.16%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.5M USD +3.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -38K USD +97.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.3M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.7M USD +3.15%
Deferred Tax Assets, Operating Loss Carryforwards 588M USD +2.23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 136M USD +7.25%
Lessee, Operating Lease, Liability, to be Paid, Year Four 24.4M USD +3.15%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.38M USD -17.4%
Share-based Payment Arrangement, Expense 15.3M USD -36.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%